Apricus Biosciences Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Apricus Biosciences

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Strong Long	3/28/2016 3:10:09 PM
	Read Replies (3) of 2026

Anyone listen to today's webcast? NDA for Vitaros US target in Q3 2016, with hope for approval 6 months hence Reduce spending by 30% by streamlining Capital needs greatly reduced Operating income needs and length of sustainability will be recalculated No mention of milestones RayVa orphan status feedback will be pursued, forgot what Pascoe said about timeframe for 2B Organic growth of Vitaros in European countries already launched Grow Vitaros Europe with additional launches in approved countries and seek approval in additional countries Well this certainly was bad news today, but I came here for Vitaros, so I guess I'll just have to suck it up and see how the original instincts line up...

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next